Applied Therapeutics Inc (APLT NASDAQ) stock market data APIs
$0.4091
0.04(9.8%)
as of September 17, 2025
Try our APIs with
free plan!
Applied Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Prev. Close
0.4091
Open
0.4468
High
0.4503
Low
0.4091
52 wk Range
0.295-10.6237
Market Cap
59 232 K
Shares Outstanding
144 M
Revenue
121 K
EPS
-0.15
Beta
2.062
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Applied Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Applied Therapeutics Inc data using free add-ons & libraries
Get Applied Therapeutics Inc Fundamental Data
Applied Therapeutics Inc Fundamental data includes:
- Net Revenue: 121 K
- EBITDA: -111 388 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: -0.17
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Applied Therapeutics Inc News
New
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders ...
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of App...
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: Grabar Law Office is investigating claims on behalf of shareholders of App...
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf
PHILADELPHIA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics (NASDAQ: APLT) – Class Action Reaches Settlement: A securities fraud class action against Applied Therapeutics, Inc. (NASDAQ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
